Peptide/NN
vaccination/NN
can/MD
lead/VB
to/TO
enhanced/VBN
tumor/NN
growth/NN
through/IN
specific/JJ
T-cell/NN
tolerance/NN
induction/NN
./.

Vaccination/NN
with/IN
synthetic/JJ
peptides/NNS
representing/VBG
cytotoxic/JJ
T/NN
lymphocyte/NN
(/(
CTL/NN
)/)
epitopes/NNS
can/MD
lead/VB
to/TO
a/DT
protective/JJ
CTL-mediated/JJ
immunity/NN
against/IN
tumors/NNS
or/CC
viruses/NNS
./.
=====
We/PRP
now/RB
report/VBP
that/IN
vaccination/NN
with/IN
a/DT
CTL/NN
epitope/NN
derived/VBN
from/IN
the/DT
human/JJ
adenovirus/NN
type/NN
5/CD
E1A-region/NN
(/(
Ad5E1A234-243/NN
)/)
,/,
which/WDT
can/MD
serve/VB
as/IN
a/DT
target/NN
for/IN
tumor-eradicating/JJ
CTL/NN
,/,
enhances/VBZ
rather/RB
than/IN
inhibits/VBZ
the/DT
growth/NN
of/IN
Ad5E1A-expressing/JJ
tumors/NNS
./.
=====
This/DT
adverse/JJ
effect/NN
of/IN
peptide/NN
vaccination/NN
was/VBD
rapidly/RB
evoked/VBN
,/,
required/VBD
low/JJ
doses/NNS
of/IN
peptide/NN
(/(
10/CD
micrograms/NNS
)/)
,/,
and/CC
was/VBD
achieved/VBN
by/IN
a/DT
mode/NN
of/IN
peptide/NN
delivery/NN
that/WDT
induces/VBZ
protective/JJ
T-cell-mediated/JJ
immunity/NN
in/IN
other/JJ
models/NNS
./.
=====
Ad5E1A-specific/JJ
CTL/NN
activity/NN
could/MD
no/RB
longer/RB
be/VB
isolated/VBN
from/IN
mice/NNS
after/IN
injection/NN
of/IN
Ad5E1A-peptide/NN
,/,
indicating/VBG
that/IN
tolerization/NN
of/IN
Ad5E1A-specific/JJ
CTL/NN
activity/NN
causes/VBZ
the/DT
enhanced/VBN
tumor/NN
outgrowth/NN
./.
=====
In/IN
contrast/NN
to/TO
peptide/NN
vaccination/NN
,/,
immunization/NN
with/IN
adenovirus/NN
,/,
expressing/VBG
Ad5E1A/NN
,/,
induced/VBD
Ad5E1A-specific/JJ
immunity/NN
and/CC
prevented/VBD
the/DT
outgrowth/NN
of/IN
Ad5E1A-expressing/JJ
tumors/NNS
./.
=====
These/DT
results/NNS
show/VBP
that/IN
immunization/NN
with/IN
synthetic/JJ
peptides/NNS
can/MD
lead/VB
to/TO
the/DT
elimination/NN
of/IN
anti-tumor/JJ
CTL/NN
responses/NNS
./.
=====
These/DT
findings/NNS
are/VBP
important/JJ
for/IN
the/DT
design/NN
of/IN
safe/JJ
peptide-based/JJ
vaccines/NNS
against/IN
tumors/NNS
,/,
allogeneic/JJ
organ/NN
transplants/NNS
,/,
and/CC
T-cell-mediated/JJ
autoimmune/JJ
diseases/NNS
./.